Aarti Drugs Q2 FY27 Profit Jumps 83% on API, Formulation Growth
Aarti Drugs’ Q2 FY27 net profit rose 83% to ₹82.8 crore as revenue grew 27% to ₹828.8 crore and the EBITDA margin hit a near six-year high of 16.6%.
AARTI-DRUGS
Aarti Drugs’ Q2 FY27 net profit rose 83% to ₹82.8 crore as revenue grew 27% to ₹828.8 crore and the EBITDA margin hit a near six-year high of 16.6%.
